ViralVectorAI: The Role and Future of AI-Driven Viral Vector Technology in Gene Editing The integration of AI and viral vector technology is revolutionizing gene editing, driving advancements in precision, intelligence, and industrial scalability. By optimizing vector design, predicting editing outc…
Lipid Nanoparticles (LNPs) in Gene Therapy and Cancer Treatment: Practical Applications Lipid nanoparticles (LNPs), as non-viral delivery vehicles, have become a core technology in gene therapy and cancer treatment due to their high nucleic acid delivery efficiency, low immunogenicity, and engineeri…
Modified RNA in Therapeutics and Vaccines: Mechanisms, Applications, and Future Challenges Modified RNA technology enhances RNA stability, translation efficiency, and immune regulation through chemical or sequence engineering, making it a cornerstone of modern drug and vaccine development. Below, we…
Precision in SynthVaccine Personalized Therapy: A Multidimensional Analysis of Technological Innovations and Clinical Practices SynthVaccine’s precision in personalized therapy distinguishes it from traditional vaccines. This precision stems from breakthroughs across the entire development chain—fro…
Challenges and Opportunities in SynthVaccine: The AI-Driven Revolution in Vaccine Design As of May 2025 Core Challenges Data Quality and Modeling Complexity Data Heterogeneity and Scarcity: SynthVaccine relies on integrating multi-omics data (genomics, epigenomics, proteomics), but inconsistent form…